welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
rareClinical
unknown status

Duchenne Muscular Dystrophy Tissue Bank for Exon Skipping

key information

study id #: NCT01772043

condition: Duchenne Muscular Dystrophy

status: unknown

purpose:

We will utilize the Cooperative International Neuromuscular Research Group (CINRG) network to collect and store tissue and blood from patients with Duchenne muscular dystrophy (DMD) with specific genetic mutations within the dystrophin gene that could be treated by antisense oligonucleotide (AO) drugs.

mechanism of action: No pharmaceutical intervention

results: https://clinicaltrials.gov/ct2/show/results/NCT01772043

last updated: November 22, 2018

study details

start date: September 2012

estimated completion: August 2016

size / enrollment: 53

study description:
The purpose of this tissue bank is to collect blood and skin samples from participants who are diagnosed with Duchenne muscular dystrophy (DMD) and carry one of nine specific changes in the dystrophin gene. The specific dystrophin changes that we are interested in studying are those that would work with exon-skipping therapies in patients with DMD, specifically deletions of the follow exons: 10-52, 13-50, 29-50, 43-52, 44, 43-50, 45-50, 45-52, 46, 46-47, 46-48, 46-49, 46-51, 46-53, 46-55, 46-60, 47-50, 47-52, 48-50, 49-50, 50, 52, 52-63, 48-52, 49-52, 50-52.
These blood and skin samples will be held in a tissue bank at Carolinas Medical Center for future DMD research.

primary outcomes:

  • Tissue Collection [ Time Frame: 1 day ]
    Collection of blood, skin and optional muscle samples

inclusion criteria:
• Age 4 and above
• Diagnosis of DMD with a confirmed out-of-frame dystrophin gene deletions that could be corrected by skipping exon 45, 51, or 53 based on past genetic testing.

exclusion criteria: Investigator assessment of inability to comply with blood and skin sample collection

study contacts

sponsor: Cooperative International Neuromuscular Research Group

locations: United States, Canada

rareRelated